Midazolam
This short-acting benzodiazepine medication produces sedation, reduces anxiety, and causes temporary memory loss, making it useful for procedural sedation and anesthesia. It acts quickly and wears off relatively fast compared to other medications in its class.
Molekularmasse
325,7670 g/mol
LogP
2,50
TPSA
30,20 Ų
Lipinski-Regel der Fünf
Bestanden
Therapeutische Bereiche
Arzneimittelklassen
Wirkmechanismus
Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.
2D-Struktur
Cite this structure
Embed this structure
SMILES
Cc1ncc2n1-c1ccc(Cl)cc1C(c1ccccc1F)=NC2
InChI
InChI=1S/C18H13ClFN3/c1-11-21-9-13-10-22-18(14-4-2-3-5-16(14)20)15-8-12(19)6-7-17(15)23(11)13/h2-9H,10H2,1H3
Molecular Formula
C18H13ClFN3
HBD / HBA
- / 3
Rotierbare Bindungen
1
Schwere Atome
23
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Häufig gestellte Fragen
This short-acting benzodiazepine medication produces sedation, reduces anxiety, and causes temporary memory loss, making it useful for procedural sedation and anesthesia. It acts quickly and wears off relatively fast compared to other medications in its class.
Ultra-short-acting benzodiazepine GABA-A receptor positive allosteric modulator.
Key pharmacokinetic parameters for Midazolam: Half-life: 1.5-2.5 hours.
Yes, Midazolam is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
Related Drugs
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL655. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 4192. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-28.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="midazolam"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/midazolam/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/midazolam/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/midazolam/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="midazolam"></drugfyi-drug>